• SoftMedx Healthcare agreed on November 2, 2026, to place up to 21,423,386 new shares with at least six independent investors.
• The HK$ 0.28 placement price represents a 13.85% discount to the closing share price on the agreement date.
• Maximum gross proceeds are approximately HK$ 6 million; estimated net proceeds total HK$ 5.67 million.
• Net proceeds will fund business operations and general working capital amid persistent challenges in medical and healthcare equipment distribution.
• Completion requires listing approval and necessary consents by November 20, 2026, unless extended by agreement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Softmedx Healthcare Limited published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261102-12395565), on November 02, 2026, and is solely responsible for the information contained therein.